-
Innovation Ranking
NewInnovation Ranking – Dare Bioscience Inc
Dare Bioscience Inc (Dare Bioscience), formerly Cerulean Pharma Inc, is a biopharmaceutical company that develops products for women’s reproductive health. The company, through its dynamic tumor targeting platform, creates nanoparticle drug conjugates to attack tumor cells, reduce toxicity by sparing the body's normal cells, and enable therapeutic combinations. It offers products that include ovaprene, a clinical stage, non-hormonal contraceptive ring that provides protection over multiple weeks of use; and topical 5% sildenafil citrate cream for women with female sexual arousal...
-
Product Insights
Reproductive Health Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Reproductive Health Devices Pipeline Market Report Overview Endometrial ablation devices, female sterilization devices, reversible contraceptive devices, and assisted reproductive technology devices are the main categories of reproductive health devices. The reproductive health devices pipeline report provides comprehensive information about the main products with their comparative segment-wise analysis at various stages of development. The report also covers the regional and country-wise reproductive health devices clinical trials outlook. The regulatory paths followed for conducting the reproductive health devices pipeline research are also...
-
Product Insights
Candidiasis – Drugs In Development, 2023
Global Markets Direct’s, ‘Candidiasis - Drugs In Development, 2023’, provides an overview of the Candidiasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Candidiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Female Contraception – Drugs In Development, 2023
Global Markets Direct’s, ‘Female Contraception - Drugs In Development, 2023’, provides an overview of the Female Contraception pipeline landscape. The report provides comprehensive information on the therapeutics under development for Female Contraception, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Mycoses – Drugs In Development, 2023
Global Markets Direct’s, ‘Mycoses - Drugs In Development, 2023’, provides an overview of the Mycoses pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mycoses, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Premature Labor (Tocolysis) – Drugs In Development, 2023
Global Markets Direct’s, ‘Premature Labor (Tocolysis) - Drugs In Development, 2023’, provides an overview of the Premature Labor (Tocolysis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Premature Labor (Tocolysis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Vasomotor Symptoms of Menopause (Hot Flashes) – Drugs In Development, 2023
Global Markets Direct’s, ‘Vasomotor Symptoms of Menopause (Hot Flashes) - Drugs In Development, 2023’, provides an overview of the Vasomotor Symptoms of Menopause (Hot Flashes) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Vasomotor Symptoms of Menopause (Hot Flashes), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Product Insights
Female Hypoactive Sexual Desire Disorder – Drugs In Development, 2023
Global Markets Direct’s, ‘Female Hypoactive Sexual Desire Disorder - Drugs In Development, 2023’, provides an overview of the Female Hypoactive Sexual Desire Disorder pipeline landscape. The report provides comprehensive information on the therapeutics under development for Female Hypoactive Sexual Desire Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy) – Drugs In Development, 2023
Global Markets Direct’s, ‘Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy) - Drugs In Development, 2023’, provides an overview of the Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Product Insights
Male Contraception – Drugs In Development, 2023
Global Markets Direct’s, ‘Male Contraception - Drugs In Development, 2023’, provides an overview of the Male Contraception pipeline landscape. The report provides comprehensive information on the therapeutics under development for Male Contraception, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...